Prognostic value of late gadolinium enhancement cardiac MRI for ICD therapy in non-ischaemic cardiomyopathy
Applying the 2023 national guidelines retrospectively on a population of NICM patients with a primary prevention ICD indication demonstrated no significant association between LGE on CMR and appropriate ICD therapy over a follow-up period of 5 years. These findings underscore the need for further research and randomised trials to refine risk stratification and ICD implantation guidelines in NICM, ideally leveraging a multicentre approach to address current limitations in sample size and enhance the generalisability of the results.
Authors
- Luuk H G A Hopman (ORCID: https://orcid.org/0000-0002-3896-9920)
- Cornelis P. Allaart (ORCID: https://orcid.org/0000-0002-0506-9512)
- Mischa T. Rijnierse (ORCID: https://orcid.org/0000-0002-0851-9689)
- Louise R.A. Olde Nordkamp (ORCID: https://orcid.org/0000-0003-2306-603X)
- Lourens Robbers (ORCID: https://orcid.org/0000-0002-8826-7628)
- Marthe A.J. Becker (ORCID: https://orcid.org/0000-0002-9742-7902)
- Anne‐Lotte C.J. van der Lingen (ORCID: https://orcid.org/0000-0003-2791-9124)
- Marco Götte (ORCID: https://orcid.org/0000-0001-9713-3675)
- Pranav Bhagirath (ORCID: https://orcid.org/0000-0003-3732-9304)
- Vokko van Halm (ORCID: https://orcid.org/0000-0002-2176-6406)
- Michiel Zumbrink
- S. Haas
Institutions
- Jeroen Bosch Ziekenhuis (NL)
Publication Details
- Journal
- Netherlands Heart Journal
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1007/s12471-025-01946-3
- Citations
- 1
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39